Xtant Medical Holdings (XTNT) Operating Income Growth (1y) (2011 - 2025)
Xtant Medical Holdings (XTNT) Operating Income Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -18.12% |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | 74.18% |
| 10 | Xtant Medical Holdings | 59.93 Mn | 42.60 Mn | 17.75 Mn | 1,043.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,043.36% |
| Sep 30, 2025 | 167.28% |
| Jun 30, 2025 | 256.96% |
| Mar 31, 2025 | 130.63% |
| Dec 31, 2024 | 50.55% |
| Sep 30, 2024 | -11.58% |
| Jun 30, 2024 | -111.79% |
| Mar 31, 2024 | -120.18% |
| Dec 31, 2023 | -120.77% |
| Sep 30, 2023 | -78.16% |
| Jun 30, 2023 | -7.00% |
| Mar 31, 2023 | 13.93% |
| Dec 31, 2022 | 9.79% |
| Sep 30, 2022 | -31.49% |
| Jun 30, 2022 | -164.77% |
| Mar 31, 2022 | -36,520.00% |
| Dec 31, 2021 | -896.25% |
| Sep 30, 2021 | -290.13% |
| Jun 30, 2021 | -26.87% |
| Mar 31, 2021 | 99.63% |